-
1.
公开(公告)号:US20060228359A1
公开(公告)日:2006-10-12
申请号:US11381977
申请日:2006-05-05
申请人: Reiner Gentz , Brent Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrik , Pablo Jimenez , Vikram Patel , Craig Rosen , Mark Adams , Haodong Li , Steven Ruben
发明人: Reiner Gentz , Brent Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrik , Pablo Jimenez , Vikram Patel , Craig Rosen , Mark Adams , Haodong Li , Steven Ruben
IPC分类号: A61K39/395 , G01N33/53 , C12N5/06 , C07K16/24
CPC分类号: G01N33/6863 , A61K38/00 , A61K48/00 , C07K1/113 , C07K1/36 , C07K14/50 , C07K14/521 , C07K14/523 , C07K16/24 , C07K2319/00 , C12N15/72 , C12N2799/026 , G01N2333/52
摘要: There are disclosed therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine β8 (CKβ8 or ckb-8)); a human monocyte-colony inhibitory factor (M-CIF) polypeptide (previously termed MIP1-γ and chemokine β1(CKβ1 or ckb-1)), and a macrophage inhibitory protein-4 (MIP-4), as well as MPIF-1, M-CIF and/or MIP-4 polypeptides themselves, as are vectors, host cells and recombinant methods for producing the same.
摘要翻译: 公开了使用编码人骨髓祖细胞抑制因子-1(MPIF-1)多肽(以前称为MIP-3和趋化因子β8(CKbeta8或ckb-8))的分离的核酸分子的治疗组合物和方法。 人单核细胞集落抑制因子(M-CIF)多肽(以前称为MIP1-γ和趋化因子β1(CKbeta1或ckb-1))和巨噬细胞抑制蛋白-4(MIP-4)以及MPIF-1 ,M-CIF和/或MIP-4多肽本身,以及用于产生它们的载体,宿主细胞和重组方法。
-
公开(公告)号:US5556767A
公开(公告)日:1996-09-17
申请号:US173209
申请日:1993-12-22
申请人: Craig A. Rosen , Haodong Li , Steven Ruben , Mark D. Adams
发明人: Craig A. Rosen , Haodong Li , Steven Ruben , Mark D. Adams
CPC分类号: C07K14/523 , C07K16/24 , A61K38/00
摘要: There is disclosed a human macrophage inflammatory protein-1 .gamma. (MIP-1 .gamma.) polypeptide and DNA(RNA) encoding such polypeptide. There is also provided a procedure for producing such polypeptide by recombinant techniques and for producing an antibody against such polypeptide. Another aspect of the invention provides a combination of the polypeptide of the present invention and a suitable pharmaceutical carrier for providing a therapeutically effective amount of the polypeptide for the treatment of various associated diseases.
摘要翻译: 公开了人巨噬细胞炎症蛋白-1(MIP-1γ)多肽和编码这种多肽的DNA(RNA)。 还提供了通过重组技术产生这种多肽并产生针对这种多肽的抗体的方法。 本发明的另一方面提供本发明的多肽和合适的药物载体的组合,用于提供治疗有效量的多肽用于治疗各种相关疾病。
-
公开(公告)号:US5958400A
公开(公告)日:1999-09-28
申请号:US766620
申请日:1996-12-13
申请人: Steven Ruben , Haodong Li , Mark D. Adams
发明人: Steven Ruben , Haodong Li , Mark D. Adams
IPC分类号: G01N33/50 , A61K31/70 , A61K31/7088 , A61K38/00 , A61K45/00 , A61K48/00 , A61P3/10 , A61P7/00 , A61P7/04 , A61P9/00 , A61P29/00 , A61P31/00 , A61P31/12 , A61P35/00 , A61P35/02 , A61P37/02 , A61P43/00 , C07H21/04 , C07K14/54 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12P21/02 , C12Q1/02 , C12Q1/68 , C12R1/19 , G01N33/15 , G01N33/566 , A61K38/20 , C12N15/24 , C12N15/63
CPC分类号: C07K14/5412 , A61K38/00 , A61K48/00
摘要: Polynucleotides which encode the polypeptide IL-6SV, as well as such polypeptides, antibodies and antagonist inhibitors against the polypeptide and the use of the polypeptide as a pharmaceutical for treating cancer, auto-immune diseases, platelet reducing conditions, anemias, bone marrow and organ transplantation.
摘要翻译: 编码多肽IL-6SV的多核苷酸,以及针对多肽的多肽,抗体和拮抗剂抑制剂以及多肽作为治疗癌症的药物,自身免疫疾病,血小板减少病症,贫血,骨髓和器官的用途 移植。
-
公开(公告)号:US20070203070A1
公开(公告)日:2007-08-30
申请号:US11744695
申请日:2007-05-04
申请人: Craig Rosen , Steven Ruben , Yi Li , Zhizhen Zeng , Hla Kyaw , Carrie Fischer , Haodong Li , Daniel Soppet , Reiner Gentz , Ying-Fei Wei , Paul Moore , Paul Young , John Greene , Ann Ferrie , Gregg Hastings
发明人: Craig Rosen , Steven Ruben , Yi Li , Zhizhen Zeng , Hla Kyaw , Carrie Fischer , Haodong Li , Daniel Soppet , Reiner Gentz , Ying-Fei Wei , Paul Moore , Paul Young , John Greene , Ann Ferrie , Gregg Hastings
IPC分类号: A61K38/17 , C07H21/04 , C07K16/00 , C07K4/00 , C12N15/00 , C12N15/09 , C12N5/00 , C12N5/08 , C12Q1/00 , C12Q1/68
CPC分类号: C07K14/47 , A61K38/00 , A61K48/00 , A61K2039/53 , C07K14/4702 , C07K14/4718 , C07K2319/00 , C07K2319/02 , C12N2799/026
摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的疾病,病症和/或病症的诊断和治疗方法。
-
公开(公告)号:US20060140905A1
公开(公告)日:2006-06-29
申请号:US11357223
申请日:2006-02-21
申请人: Haodong Li , Steven Ruben , Theodora Salcedo , Vikram Patel , Robert Nibbs , Gerard Graham
发明人: Haodong Li , Steven Ruben , Theodora Salcedo , Vikram Patel , Robert Nibbs , Gerard Graham
CPC分类号: C07K14/523 , A61K38/00
摘要: The present invention relates to deletion and substitution mutant polypeptides of human chemokine β-7 (Ckβ-7), as well as nucleic acid molecules encoding such polypeptides and processes for producing such polypeptides using recombinant techniques. In one aspect, the invention also relates to uses of the full-length and mature forms of Ckβ-7, as well as deletion and substitution mutants, in medical treatment regimens. In particular, the Ckβ-7 polypeptides described herein may be employed to treat a variety of conditions, including rheumatoid arthritis, inflammation, respiratory diseases, allergy, and IgE-mediated allergic reactions.
-
公开(公告)号:US20050208621A1
公开(公告)日:2005-09-22
申请号:US10951993
申请日:2004-09-29
申请人: Craig Rosen , Steven Ruben , Yi Li , ZhiZhen Zeng , Hla Kyaw , Carrie Fishcher , Haodong Li , Daniel Soppet , Reiner Gentz , Ying-Fei Wei , Paul Moore , Paul Young , John Greene , Ann Ferrie , Gregg Hastings
发明人: Craig Rosen , Steven Ruben , Yi Li , ZhiZhen Zeng , Hla Kyaw , Carrie Fishcher , Haodong Li , Daniel Soppet , Reiner Gentz , Ying-Fei Wei , Paul Moore , Paul Young , John Greene , Ann Ferrie , Gregg Hastings
CPC分类号: C07K14/47 , A61K38/00 , A61K48/00 , A61K2039/53 , C07K14/4702 , C07K14/4718 , C07K2319/00 , C07K2319/02 , C12N2799/026
摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的疾病,病症和/或病症的诊断和治疗方法。
-
公开(公告)号:US20050118680A1
公开(公告)日:2005-06-02
申请号:US11035998
申请日:2005-01-18
申请人: Haodong Li , Steven Ruben , Granger Sutton
发明人: Haodong Li , Steven Ruben , Granger Sutton
CPC分类号: C07K14/523 , A61K38/00
摘要: A human chemotactic polypeptide, DNA (RNA) encoding it, and a procedure for producing such a polypeptide by recombinant techniques are disclosed. Also disclosed are methods of using the polypeptide for a number of purposes, including: stem cell mobilization, myeloprotection, neuronal protection, treating tumors, wound healing, treating parasitic infection, and regulating hematopoiesis. Also disclosed are polypeptide antagonists and diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases are also disclosed.
摘要翻译: 公开了人趋化多肽,编码它的DNA(RNA)和通过重组技术产生这种多肽的方法。 还公开了将多肽用于多种目的的方法,包括:干细胞动员,髓过保护,神经元保护,治疗肿瘤,伤口愈合,治疗寄生虫感染和调节造血。 还公开了多肽拮抗剂和用于鉴定编码本发明多肽的核酸序列中的突变并用于检测用于检测疾病的本发明多肽的改变水平的诊断测定。
-
公开(公告)号:US5641657A
公开(公告)日:1997-06-24
申请号:US246427
申请日:1994-05-19
申请人: Steven Ruben , Haodong Li , Mark D. Adams
发明人: Steven Ruben , Haodong Li , Mark D. Adams
IPC分类号: G01N33/50 , A61K31/70 , A61K31/7088 , A61K38/00 , A61K45/00 , A61K48/00 , A61P3/10 , A61P7/00 , A61P7/04 , A61P9/00 , A61P29/00 , A61P31/00 , A61P31/12 , A61P35/00 , A61P35/02 , A61P37/02 , A61P43/00 , C07H21/04 , C07K14/54 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12P21/02 , C12Q1/02 , C12Q1/68 , C12R1/19 , G01N33/15 , G01N33/566 , C12N15/24
CPC分类号: C07K14/5412 , A61K38/00 , A61K48/00
摘要: Polynucleotides which encode the polypeptide IL-6SV, as well as such polypeptides, antibodies and antagonist inhibitors against the polypeptide and the use of the polypeptide as a pharmaceutical for treating cancer, auto-immune diseases, platelet reducing conditions, anemias, bone marrow and organ transplantation.
摘要翻译: 编码多肽IL-6SV的多核苷酸,以及针对多肽的多肽,抗体和拮抗剂抑制剂以及多肽作为治疗癌症的药物,自身免疫疾病,血小板减少病症,贫血,骨髓和器官的用途 移植。
-
公开(公告)号:US5504003A
公开(公告)日:1996-04-02
申请号:US208339
申请日:1994-03-08
申请人: Haodong Li , Steven Ruben
发明人: Haodong Li , Steven Ruben
CPC分类号: C07K14/523 , C07K16/24 , A61K38/00
摘要: There is disclosed a human macrophage inflammatory protein-3 (MIP-3) and a human macrophage inflammatory protein-4 (MIP-4) polypeptides and DNA (RNA) encoding such polypeptides. There is also provided a procedure for producing such polypeptides by recombinant techniques and for producing antibodies against such polypeptides. In the invention there is also provided antagonist/inhibitors against such polypeptides which inhibit the functioning of such polypeptides. Another aspect of the invention provides a combination of the polypeptides of the present invention and a suitable pharmaceutical carrier for providing a therapeutically effective amount of the polypeptides for the treatment of various associated diseases.
摘要翻译: 公开了人巨噬细胞炎症蛋白-3(MIP-3)和人巨噬细胞炎症蛋白-4(MIP-4)多肽和编码这种多肽的DNA(RNA)。 还提供了通过重组技术产生这种多肽并产生针对这种多肽的抗体的方法。 在本发明中,还提供了抑制这种多肽功能的这种多肽的拮抗剂/抑制剂。 本发明的另一方面提供了本发明的多肽和合适的药物载体的组合,用于提供治疗有效量的多肽用于治疗各种相关疾病。
-
10.
公开(公告)号:US07364865B2
公开(公告)日:2008-04-29
申请号:US11381977
申请日:2006-05-05
申请人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
发明人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
CPC分类号: G01N33/6863 , A61K38/00 , A61K48/00 , C07K1/113 , C07K1/36 , C07K14/50 , C07K14/521 , C07K14/523 , C07K16/24 , C07K2319/00 , C12N15/72 , C12N2799/026 , G01N2333/52
摘要: There are disclosed therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine β8 (CKβ8 or ckb-8)); a human monocyte-colony inhibitory factor (M-CIF) polypeptide (previously termed MIP1-γ and chemokine β1(CKβ1 or ckb-1)), and a macrophage inhibitory protein-4 (MIP-4), as well as MPIF-1, M-CIF and/or MIP-4 polypeptides themselves, as are vectors, host cells and recombinant methods for producing the same.
摘要翻译: 公开了使用编码人骨髓祖细胞抑制因子-1(MPIF-1)多肽(以前称为MIP-3和趋化因子β8(CKbeta8或ckb-8))的分离的核酸分子的治疗组合物和方法。 人单核细胞集落抑制因子(M-CIF)多肽(以前称为MIP1-γ和趋化因子β1(CKbeta1或ckb-1))和巨噬细胞抑制蛋白-4(MIP-4)以及MPIF-1 ,M-CIF和/或MIP-4多肽本身,以及用于产生它们的载体,宿主细胞和重组方法。
-
-
-
-
-
-
-
-
-